Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) targets 23 common serotypes and is recommended for use in adults in various countries to protect against pneumococcal infection. Test-negative design (TND) studies aim to include cases and controls from the same healthcare facilities; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Cossrow, Nicole, Joshi, Rennie, Klinker, Kenneth, Buchwald, Ulrike K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611352/
https://www.ncbi.nlm.nih.gov/pubmed/36296263
http://dx.doi.org/10.3390/microorganisms10101987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611352/
https://www.ncbi.nlm.nih.gov/pubmed/36296263
http://dx.doi.org/10.3390/microorganisms10101987

Ejemplares similares